These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25344216)

  • 1. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
    Zhang Z; Wang Q; Chen F; Liu J
    Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
    Huang R; Huang D; Dai W; Yang F
    Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
    Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
    Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.
    Qian X; Song X; He Y; Yang Z; Sun T; Wang J; Zhu G; Xing W; You C
    Biomed Pharmacother; 2015 Aug; 74():222-7. PubMed ID: 26349989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD; Sun Y; Shen H; Li W
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.
    Saed L; Balcerczak E; Łochowski M; Olechnowicz E; Sałagacka-Kubiak A
    Mol Genet Genomics; 2022 Nov; 297(6):1505-1514. PubMed ID: 35948739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of FSCN1 in non-small cell lung cancer.
    Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
    Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.
    Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM
    Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
    Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
    Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
    Lin R; Shen W; Zhi Y; Zhou Z
    Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer.
    Wang YZ; Wu KP; Wu AB; Yang ZC; Li JM; Mo YL; Xu M; Wu B; Yang ZX
    Tumour Biol; 2014 Oct; 35(10):9815-21. PubMed ID: 24986569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.
    Li C; Wang G; Ma X; Tao T; Li Q; Yang Y; Sang H; Wang Z
    Bioengineered; 2022 Feb; 13(2):4185-4200. PubMed ID: 35114891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of
    Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of
    Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.